A carregar...
Cetuximab in Refractory Skin Cancer Treatment
Objectives: Non-melanoma skin cancer is the most common malignancy in US, with an annual incidence of in excess of 1.5 million cases. In the majority of cases, locoregional treatment is curative and systemic therapy is not indicated. Platinum-based chemotherapy regimens have been used most commonly...
Na minha lista:
| Main Authors: | , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Ivyspring International Publisher
2012
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3376776/ https://ncbi.nlm.nih.gov/pubmed/22712026 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7150/jca.3491 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|